Press Releases

Below you will find the latest press releases from Evolva. You are also welcome to dive into the archive and browse our press releases from there as well:

Latest Press Releases

Reinach, Switzerland, 28 May 2014 – Evolva Holding SA (SIX: EVE) today announces the start of commercial production of its resveratrol ingredient.

Reinach, Switzerland, 23 May 2014 – The Annual General Meeting of Evolva Holding SA (SIX: EVE) has approved all proposals put forward by the Board of Directors.

Minneapolis and Reinach, Switzerland, 21 May 2014 – Cargill and Evolva Holding SA (SIX: EVE) today announced the achievement of a technical milestone in their joint development program of fermentation-based minor steviol glycosides - the compounds responsible for the sweet taste in the stevia leaf.

Reinach, Switzerland, 2 May 2014 – Evolva Holding SA (SIX: EVE) today announces the agenda for its Annual General Meeting of shareholders (AGM), to be held on 23 May 2014 in Basel, Switzerland. The full agenda is available on Evolva’s website under “investors/shareholder information”.

Reinach, Switzerland, 8 April 2014 – Evolva Holding SA (SIX: EVE) today announces its financial results for the period 1 January to 31 December 2013. The annual report is available on Evolva’s website.

Reinach, Switzerland, 5 March 2014 - Evolva Holding SA (SIX: EVE, “Evolva” or the “Company”) announces that Credit Suisse, who is acting as Sole Bookrunner in the private placement announced on 25 February 2014, has exercised in full the over-allotment option of 4,050,000 shares at the placement price of CHF 1.37 per share.

Reinach, Switzerland, 4 March 2014 – Evolva Holding SA (SIX: EVE) today announces that Roquette Frères SA (Roquette) has confirmed that Evolva has achieved the second R&D milestone in their collaboration.

Reinach, Switzerland, 26 February 2014 - Evolva Holding SA (SIX: EVE, “Evolva” or the “Company”) has successfully completed its placement of shares which was announced yesterday. Evolva has sold 27,000,000 new shares via an accelerated bookbuild process

Reinach, Switzerland, 25 February 2014 - Evolva Holding SA reports preliminary, unaudited financial results for 2013 and announces launch of share placement

Contact Information

Evolva SA
Duggingerstrasse 23
CH-4153 Reinach
Switzerland
Tel: +41 61 485 2000
Fax: +41 61 485 2001
Evolva A/S
Lersoe Parkallé 42-44
DK-2100 Copenhagen OE
Denmark
Tel: +45 35 200 230
Fax: +45 35 200 231
Evolva Biotech Private Limited
401 - 405, 4th Floor
Ticel Bio Park Ltd
Taramani Road, Taramani
Chennai 600 113
Tamil Nadu, India
Tel: +91 44 4297 1050
Fax: +91 44 4297 1060
Evolva, Inc. (Evolva USA)
2440 Embarcadero Way
Palo Alto
CA 94303
USA
Tel: +1 650 856 2436
Fax: +1 650 856 7950

General Enquiries: info@evolva.com • Business Enquiries: busdev@evolva.com • India Enquiries: info_india@evolva.com